RAC Charts, page-1805

First 1805 Last

Share
Profile

Follow
Roger233

697 Posts.

78

23/12/24

22:48

Post #: 77171437
Share

Originally posted by Inkling: ↑

I know nothing about TA but I definitely respect those that do and think it has merit. But, for me I own race shares simply because I seriously believe in the fundamentals.

I know this will sound simple minded but I’m invested here because I think that it’s ‘inevitable’ that big pharma will notice race eventually and make an offer. As a result I am not trading, not trying to time anything and probably just waiting until a buyout. A simple strategy.

Obviously a buyout is not inevitable, but that raises the question/ topic I am trying to bring up.

How much will the success of race depend on
a) the drug
b) the team/ external factors?

I’m invested relatively heavily in race because I believe bisantrene is an absolute winner. Although I think the current team are decent, it’s all been a bit turbulent and things keep taking longer than we would like. But I’ve held on because the drug seems outstanding.

So my question is- if you have an awesome drug, can you expect a large buyout with an average team? Or are there lots of incredible drugs being discovered that fail to make it to market for various reasons?

Patents, clinical trials, none of this stuff is easy. Especially for a small Aussie biotech. But then I’m only holding because bisantrene seems awesome, and I hope the team is capable of dealing with the opportunity. And my simple brain says keep it simple and just buy and hold.

This may not be the right thread for this question. But it is basically me asking: how much can awesome fundamentals override everything else long term (including TA). Obviously the answer lies somewhere in between but this might be the biggest question I ponder about race… so thoughts are welcome.

Expand

good post.Ill give some thoughts tomorrow

RAC Price at posting: $1.34 Sentiment: Hold Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

TKM

Trek Metals brings in another drill rig to dive deeper at Christmas Creek

GRE

Juicy copper-zinc target brings GreenTech closer to near-term Whundo production

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

XRO

'Step-change' for Xero internationally with $3.9B deal to buy US bill pay platform

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

First 1805 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.22		Change 0.000(0.00%)		Mkt cap ! $212.8M

Open	High	Low	Value	Volume
$1.24	$1.26	$1.22	$57.47K	46.25K

Buyers (Bids)

No.	Vol.	Price($)
1	4163	$1.22

Sellers (Offers)

Price($)	Vol.	No.
$1.24	423	1

View Market Depth

No.	Vol.	Price($)
1	4289	1.220
1	1485	1.215
3	7276	1.210
6	33407	1.200
3	21667	1.190

Price($)	Vol.	No.
1.235	423	1
1.250	8858	2
1.260	10432	2
1.270	637	1
1.280	4060	1

Last trade - 11.51am 25/06/2025 (20 minute delay)

RAC (ASX) Chart

RAC Charts, page-1805

Top Stories

Trek Metals brings in another drill rig to dive deeper at Christmas Creek

Juicy copper-zinc target brings GreenTech closer to near-term Whundo production

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

'Step-change' for Xero internationally with $3.9B deal to buy US bill pay platform

Australia’s gas crisis is here – and dying coal plants aren’t helping

Buyers (Bids)

Sellers (Offers)